366.58 USD
+1.93 (+0.53%)
At close: Feb 11, 2026
366.75 USD
+0.17 (+0.05%)
After Hours: 2/11/2026, 7:06:25 PM
We assign a fundamental rating of 5 out of 10 to AMGN. AMGN was compared to 523 industry peers in the Biotechnology industry. AMGN has an excellent profitability rating, but there are concerns on its financial health. AMGN is not valued too expensively and it also shows a decent growth rate. AMGN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- AMGN had positive earnings in the past year.
- In the past year AMGN had a positive cash flow from operations.
- Each year in the past 5 years AMGN has been profitable.
- AMGN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 8.51%, AMGN belongs to the top of the industry, outperforming 93.12% of the companies in the same industry.
- The Return On Equity of AMGN (89.06%) is better than 99.24% of its industry peers.
- AMGN has a Return On Invested Capital of 16.85%. This is amongst the best in the industry. AMGN outperforms 96.56% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for AMGN is below the industry average of 18.27%.
- The 3 year average ROIC (14.35%) for AMGN is below the current ROIC(16.85%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 89.06% | ||
| ROIC | 16.85% |
ROA(3y)6.63%
ROA(5y)7.92%
ROE(3y)88.81%
ROE(5y)106.67%
ROIC(3y)14.35%
ROIC(5y)15.45%
1.3 Margins
- AMGN has a better Profit Margin (20.98%) than 94.07% of its industry peers.
- In the last couple of years the Profit Margin of AMGN has declined.
- Looking at the Operating Margin, with a value of 34.19%, AMGN belongs to the top of the industry, outperforming 97.51% of the companies in the same industry.
- In the last couple of years the Operating Margin of AMGN has grown nicely.
- AMGN's Gross Margin of 73.30% is amongst the best of the industry. AMGN outperforms 82.79% of its industry peers.
- In the last couple of years the Gross Margin of AMGN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.19% | ||
| PM (TTM) | 20.98% | ||
| GM | 73.3% |
OM growth 3Y4.6%
OM growth 5Y4.15%
PM growth 3Y-5.54%
PM growth 5Y-5.99%
GM growth 3Y2.93%
GM growth 5Y1.72%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMGN is creating some value.
- AMGN has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, AMGN has less shares outstanding
- Compared to 1 year ago, AMGN has an improved debt to assets ratio.
2.2 Solvency
- The Debt to FCF ratio of AMGN is 6.74, which is on the high side as it means it would take AMGN, 6.74 years of fcf income to pay off all of its debts.
- AMGN has a Debt to FCF ratio of 6.74. This is amongst the best in the industry. AMGN outperforms 91.59% of its industry peers.
- AMGN has a Debt/Equity ratio of 5.78. This is a high value indicating a heavy dependency on external financing.
- AMGN has a worse Debt to Equity ratio (5.78) than 80.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.78 | ||
| Debt/FCF | 6.74 | ||
| Altman-Z | N/A |
ROIC/WACC1.38
WACC12.19%
2.3 Liquidity
- AMGN has a Current Ratio of 1.14. This is a normal value and indicates that AMGN is financially healthy and should not expect problems in meeting its short term obligations.
- AMGN's Current ratio of 1.14 is on the low side compared to the rest of the industry. AMGN is outperformed by 84.51% of its industry peers.
- A Quick Ratio of 0.90 indicates that AMGN may have some problems paying its short term obligations.
- With a Quick ratio value of 0.90, AMGN is not doing good in the industry: 85.85% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
- AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.24%, which is quite good.
- Measured over the past 5 years, AMGN shows a small growth in Earnings Per Share. The EPS has been growing by 5.65% on average per year.
- The Revenue has grown by 9.95% in the past year. This is quite good.
- AMGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.65% yearly.
EPS 1Y (TTM)10.24%
EPS 3Y7.29%
EPS 5Y5.65%
EPS Q2Q%-0.38%
Revenue 1Y (TTM)9.95%
Revenue growth 3Y11.77%
Revenue growth 5Y7.65%
Sales Q2Q%8.58%
3.2 Future
- Based on estimates for the next years, AMGN will show a small growth in Earnings Per Share. The EPS will grow by 4.94% on average per year.
- AMGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.16% yearly.
EPS Next Y3.12%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
EPS Next 5Y4.94%
Revenue Next Year2.04%
Revenue Next 2Y2.46%
Revenue Next 3Y1.68%
Revenue Next 5Y3.16%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 16.78 indicates a correct valuation of AMGN.
- AMGN's Price/Earnings ratio is rather cheap when compared to the industry. AMGN is cheaper than 95.60% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.23. AMGN is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 16.27, the valuation of AMGN can be described as correct.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of AMGN indicates a rather cheap valuation: AMGN is cheaper than 95.41% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of AMGN to the average of the S&P500 Index (28.01), we can say AMGN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.78 | ||
| Fwd PE | 16.27 |
4.2 Price Multiples
- AMGN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMGN is cheaper than 94.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.37 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMGN does not grow enough to justify the current Price/Earnings ratio.
- The excellent profitability rating of AMGN may justify a higher PE ratio.
PEG (NY)5.37
PEG (5Y)2.97
EPS Next 2Y3.35%
EPS Next 3Y2.5%
5. Dividend
5.1 Amount
- AMGN has a Yearly Dividend Yield of 2.76%.
- Compared to an average industry Dividend Yield of 1.14, AMGN pays a better dividend. On top of this AMGN pays more dividend than 98.85% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.79, AMGN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.76% |
5.2 History
- On average, the dividend of AMGN grows each year by 9.41%, which is quite nice.
- AMGN has paid a dividend for at least 10 years, which is a reliable track record.
- AMGN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)9.41%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
- The dividend of AMGN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
366.58
+1.93 (+0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-03 2026-02-03/amc
Earnings (Next)04-29 2026-04-29/amc
Inst Owners83.87%
Inst Owner Change-1.4%
Ins Owners0.06%
Ins Owner Change-0.79%
Market Cap197.40B
Revenue(TTM)36.75B
Net Income(TTM)7.71B
Analysts71.71
Price Target341.81 (-6.76%)
Short Float %2.6%
Short Ratio4.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.76% |
Yearly Dividend9.01
Dividend Growth(5Y)9.41%
DP0%
Div Incr Years13
Div Non Decr Years13
Ex-Date02-13 2026-02-13 (2.52)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.92%
Min EPS beat(2)9.56%
Max EPS beat(2)10.28%
EPS beat(4)4
Avg EPS beat(4)10.8%
Min EPS beat(4)9.56%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)6.29%
EPS beat(12)11
Avg EPS beat(12)5.41%
EPS beat(16)14
Avg EPS beat(16)4.51%
Revenue beat(2)2
Avg Revenue beat(2)3.3%
Min Revenue beat(2)2.11%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.61%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)2.13%
PT rev (3m)6.94%
EPS NQ rev (1m)0.84%
EPS NQ rev (3m)0.68%
EPS NY rev (1m)0.6%
EPS NY rev (3m)2.41%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)2.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.78 | ||
| Fwd PE | 16.27 | ||
| P/S | 5.37 | ||
| P/FCF | 24.37 | ||
| P/OCF | 19.82 | ||
| P/B | 22.8 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)21.85
EY5.96%
EPS(NY)22.53
Fwd EY6.15%
FCF(TTM)15.04
FCFY4.1%
OCF(TTM)18.49
OCFY5.04%
SpS68.25
BVpS16.08
TBVpS-59.98
PEG (NY)5.37
PEG (5Y)2.97
Graham Number88.91
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 89.06% | ||
| ROCE | 19.3% | ||
| ROIC | 16.85% | ||
| ROICexc | 19.6% | ||
| ROICexgc | 73.08% | ||
| OM | 34.19% | ||
| PM (TTM) | 20.98% | ||
| GM | 73.3% | ||
| FCFM | 22.04% |
ROA(3y)6.63%
ROA(5y)7.92%
ROE(3y)88.81%
ROE(5y)106.67%
ROIC(3y)14.35%
ROIC(5y)15.45%
ROICexc(3y)16.88%
ROICexc(5y)18.44%
ROICexgc(3y)72.7%
ROICexgc(5y)79.08%
ROCE(3y)16.43%
ROCE(5y)17.69%
ROICexgc growth 3Y-3.21%
ROICexgc growth 5Y2.03%
ROICexc growth 3Y4.63%
ROICexc growth 5Y5.17%
OM growth 3Y4.6%
OM growth 5Y4.15%
PM growth 3Y-5.54%
PM growth 5Y-5.99%
GM growth 3Y2.93%
GM growth 5Y1.72%
F-Score7
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.78 | ||
| Debt/FCF | 6.74 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 5.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 105.05% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | N/A |
F-Score7
WACC12.19%
ROIC/WACC1.38
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)4.09%
Cap/Sales(5y)3.84%
Profit Quality(3y)156.25%
Profit Quality(5y)149.01%
High Growth Momentum
Growth
EPS 1Y (TTM)10.24%
EPS 3Y7.29%
EPS 5Y5.65%
EPS Q2Q%-0.38%
EPS Next Y3.12%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
EPS Next 5Y4.94%
Revenue 1Y (TTM)9.95%
Revenue growth 3Y11.77%
Revenue growth 5Y7.65%
Sales Q2Q%8.58%
Revenue Next Year2.04%
Revenue Next 2Y2.46%
Revenue Next 3Y1.68%
Revenue Next 5Y3.16%
EBIT growth 1Y73.11%
EBIT growth 3Y16.9%
EBIT growth 5Y12.12%
EBIT Next Year31.54%
EBIT Next 3Y9.81%
EBIT Next 5Y8.21%
FCF growth 1Y-22.07%
FCF growth 3Y-2.67%
FCF growth 5Y-3.91%
OCF growth 1Y-13.33%
OCF growth 3Y0.81%
OCF growth 5Y-1.05%
AMGEN INC / AMGN FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to AMGN.
What is the valuation status of AMGEN INC (AMGN) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (AMGN). This can be considered as Fairly Valued.
What is the profitability of AMGN stock?
AMGEN INC (AMGN) has a profitability rating of 8 / 10.
How financially healthy is AMGEN INC?
The financial health rating of AMGEN INC (AMGN) is 3 / 10.
What is the earnings growth outlook for AMGEN INC?
The Earnings per Share (EPS) of AMGEN INC (AMGN) is expected to grow by 3.12% in the next year.